Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Braz. j. med. biol. res ; 53(4): e9200, 2020. tab, graf
Article in English | LILACS | ID: biblio-1089350

ABSTRACT

The consumption of alcoholic beverages influences carbohydrate and lipid metabolism, although it is not yet clear whether metabolism during physical exercise at different intensities is also affected. This was the objective of the present study. Eight young and healthy volunteers performed a treadmill test to identify the running speed corresponding to a lactate concentration of 4 mM (S4mM). At least 48 h later, they were subjected to two experimental trials (non-alcohol or alcohol) in which they performed two 1-km running sessions at the following intensities: 1) S4mM; 2) 15% above S4mM. In both trials, blood lactate, triglycerides, and glucose concentrations were measured before and after exercise. The acute alcohol intake increased triglycerides, but not lactate concentration under resting conditions. Interestingly, alcohol intake enhanced the exercise-induced increase in lactate concentration at the two intensities: S4mM (non-alcohol: 4.2±0.3 mM vs alcohol: 4.8±0.9 mM; P=0.003) and 15% above S4mM trial (P=0.004). When volunteers ingested alcohol, triglycerides concentration remained increased after treadmill running (e.g., at S4mM - at rest; non-alcohol: 0.2±0.5 mM vs alcohol: 1.3±1.3 mM; P=0.048). In contrast, glucose concentration was not modified by either alcohol intake, exercise, or their combination. We concluded that an acute alcohol intake changed lactate and lipid metabolism without affecting blood glucose concentration. In addition, the increase in lactate concentration caused by alcohol was specifically observed when individuals exercised, whereas augmented triglycerides concentration was already observed before exercise and was sustained thereafter.


Subject(s)
Humans , Male , Adult , Young Adult , Physical Endurance/drug effects , Blood Glucose/metabolism , Alcohol Drinking/blood , Lactic Acid/blood , Ethanol/metabolism , Alcoholic Beverages/analysis , Physical Endurance/physiology , Triglycerides/blood , Blood Glucose/analysis , Exercise Test , Athletic Performance/physiology
2.
Arq. bras. med. vet. zootec. (Online) ; 70(6): 1911-1915, nov.-dez. 2018. ilus
Article in Portuguese | LILACS, VETINDEX | ID: biblio-970665

ABSTRACT

O objetivo deste trabalho foi relatar um caso raro de hidrocefalia em um felino doméstico, da raça Persa, de 30 dias de idade. O animal foi atendido com histórico de impossibilidade de manter-se em estação, incoordenação motora, inabilidade para se alimentar sozinho e sustentar o peso da cabeça. No exame clínico, foi observada presença de fontanela aberta, aumento de calota craniana, ataxia, estrabismo unilateral e secreção ocular. A realização de ultrassonografia do crânio levou à confirmação do diagnóstico de hidrocefalia. O paciente permaneceu internado, sendo o protocolo de tratamento empregado constituído de corticosteroide, diurético e protetor gástrico em alta dose, além de alimentação por via oral e fluidoterapia. O animal veio a óbito após 24 horas, sendo encaminhado para realização de necropsia.(AU)


The objective of this work was to report a rare case of hydrocephalus in a domestic Persian feline, 30 days old. The animal was attended with a history of inability to keep in season, incoordination of the motor, inability to feed itself and support the weight of the head. In the clinical examination, the presence of an open fontanelle, an increase in the skull cap, ataxia, unilateral strabismus and ocular secretion were observed. The ultrasound examination of the skull led to confirmation of the diagnosis of hydrocephalus. The patient remained hospitalized, and the treatment protocol consisted of a corticosteroid, diuretic and gastric protector in high dose, besides oral feeding and fluid therapy. The animal died after 24 hours, being referred for necropsy.(AU)


Subject(s)
Animals , Cats , Cats/abnormalities , Hydrocephalus/classification , Hydrocephalus/diagnosis , Cerebrospinal Fluid
3.
Int. j. morphol ; 35(3): 864-869, Sept. 2017.
Article in Spanish | LILACS | ID: biblio-893065

ABSTRACT

Este artículo presenta un análisis desde el punto de vista bibliográfico de marcadores y biomarcadores de la enfermedad de Alzheimer (EA). Las metodologías usadas fueron los marcadores de imágenes (Resonancia Magnética y Tomografía por emisión de positrones) y biomarcadores de la proteína BA42, de la proteína Tau y de la Apoliproteína E (ALPE). De esta manera, son de importancia los niveles de BA42 disminuidos, la Tau incrementada, los polimorfismos de ALPE y las alteraciones constatadas en los marcadores de imagen, como factores de riesgo esenciales para el desarrollo de la EA. Se realiza una revisión de la literatura con respecto a los hallazgos clínicos de esta enfermedad.


This article presents a bibliographical analysis of markers and biomarkers of Alzheimer's disease (AD). The methodologies used were the imaging markers (Magnetic Resonance and Positron Emission Tomography) and biomarkers of the BA42 protein, Tau protein and Apoliprotein E (ALPE). Thus, decreased levels of BA42, increased Tau, ALPE polymorphisms, and alterations in imaging markers are important as risk factors for the development of AD. A review of the literature is made regarding the clinical findings of this disease.


Subject(s)
Humans , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/metabolism , Biomarkers/metabolism , Alzheimer Disease/physiopathology , Apolipoproteins E/metabolism , Magnetic Resonance Imaging , Positron-Emission Tomography , tau Proteins/metabolism
4.
Int. j. morphol ; 33(4): 1518-1524, Dec. 2015. ilus
Article in Spanish | LILACS | ID: lil-772347

ABSTRACT

El presente estudio tuvo como objetivo evaluar el efecto del compuesto fenólico polifuncional DM1 sobre el comportamiento motor, exploratório y ansiedad en ratas Wistar, analizadas en campo abierto (CA) y laberinto en cruz elevada (LCE). Se utilizaron 40 ratas Wistar adultas, divididas en 5 grupos (n= 8): Control (vehículo), DZP (Diazepam-2 mg/kg), DM1-150 mg/kg, DM1-300 mg/kg y DM1-450 mg/kg. Los animales fueron evaluados por un período de cinco minutos en CA y en el LCE, 30 min después de las administraciones (vía intraperitoneal). La evaluación en CA demostró reducción de la locomoción en los grupos DZP, DM1-300 y DM1-450 en relación al grupo control. Aumentó la locomoción en el grupo DM1-150 en relación al grupo DZP y disminuyó la locomoción en el grupo DM1-300 en relación al grupo DM1-150. Hubo disminución del levantar del grupo DZP en relación al grupo control. El grupo DM1-150 presentó aumento del levantar en relación al grupo DZP. Aumentó el tiempo estático (TE) en el grupo DZP y se redujo en el grupo DM1-300, ambos en relación al grupo control. El grupo DM1-150 presentó disminución del TE en relación al grupo DZP. La evaluación LCE presentó reducción del número de entradas en los brazos abiertos en el grupo DZP en relación al grupo control. Hubo reducción del número de entradas en los brazos cerrados en el grupo DZP en relación al grupo control y aumento de este parámetro en el grupo DM1-150 mg en relación al grupo DZP. Se redujó el número de cruzamientos entre los brazos cerrados en el grupo DZP en relación al grupo control. Los resultados en conjunto, sugieren que las dosis del compuesto fenólico polifuncional DM1 por sobre 150mg, tienen influencia en el estado emocional de los animales, indicando posible acción sedativa con probable inducción de relajamiento muscular.


This study aimed to evaluate the effect of polyfunctional phenolic compound DM1 on the motor behavior, exploratory and anxiety in Wistar rats tested in open field (OF) and in elevated plus-maze (EPM). We used 40 adult Wistar rats divided in 5 groups (n= 8): Control (vehicle), DZP (diazepam-2 mg/kg), DM1-150 mg/kg, DM1-300 mg/kg and DM1-450 mg/kg. The animals were evaluated for a period of five minutes in the OF and EPM, 30 min after administrations (intraperitoneally). The evaluation in OF showed reduction in the locomotion in the DZP, DM1-300 and DM1-450 groups relative to the control group. It increased locomotion in DM1-150 group relative to the DZP group and decreased locomotion in DM1-300 group relative to the group DM1-150. There was decrease of the lifting action in the DZP group relative to the control group. The DM1-150 group presented increase of the lifting action compared to DZP group. It increased the static time (ST) in the DZP group and decreased in the DM1-300 group, both in relation to the control group. The DM1-150 group presented decrease of the ST compared to DZP group. The EPM evaluation presented reducing the number of entries into the open arms in the DZP group relative to the control group. There was reduction in the number of entries into the closed arms in the DZP group relative to the control and increase of this parameter in the DM1-150 group in relation to DZP group. The number of crossings between the closed arms in the DZP group relative to the control group decreased. The overall results suggest that the dose of polyfunctional phenolic compound DM1 above 150 mg have influence on the emotional state of the animals, indicating possible sedative action likely induction of muscle relaxation.


Subject(s)
Animals , Rats , Behavior, Animal/drug effects , Motor Activity/drug effects , Polyphenols/administration & dosage , Anxiety , Maze Learning , Polyphenols/pharmacology , Rats, Wistar
5.
Braz. j. med. biol. res ; 39(5): 615-620, May 2006. tab
Article in English | LILACS | ID: lil-425793

ABSTRACT

Acute promyelocytic leukemia (APL) is characterized by the expansion of blasts that resemble morphologically promyelocytes and harbor a chromosomal translocation involving the retinoic acid receptor a (RARa) and the promyelocytic leukemia (PML) genes on chromosomes 17 and 15, respectively. The expression of the PML/RARa fusion gene is essential for APL genesis. In fact, transgenic mice (TM) expressing PML/RARa develop a form of leukemia that mimics the hematological findings of human APL. Leukemia is diagnosed after a long latency (approximately 12 months) during which no hematological abnormality is detected in peripheral blood (pre-leukemic phase). In humans, immunophenotypic analysis of APL blasts revealed distinct features; however, the precise immunophenotype of leukemic cells in the TM model has not been established. Our aim was to characterize the expression of myeloid antigens by leukemic cells from hCG-PML/RARa TM. In this study, TM (N = 12) developed leukemia at the mean age of 13.1 months. Morphological analysis of bone marrow revealed an increase of the percentage of immature myeloid cells in leukemic TM compared to pre-leukemic TM and wild-type controls (48.63 ± 16.68, 10.83 ± 8.11, 7.4 ± 5.46 percent, respectively; P < 0.05). Flow cytometry analysis of bone marrow and spleen from leukemic TM identified the asynchronous co-expression of CD34, CD117, and CD11b. This abnormal phenotype was rarely detected prior to the diagnosis of leukemia and was present at similar frequencies in hematologically normal TM and wild-type controls of different ages. The present results demonstrate that, similarly to human APL, leukemic cells from hCG-PML/RARa TM present a specific immunophenotype.


Subject(s)
Animals , Mice , Antigens, CD/immunology , Leukemia, Myeloid, Acute/immunology , Leukemia, Promyelocytic, Acute/immunology , Oncogene Proteins, Fusion/immunology , Antigens, CD/genetics , Bone Marrow/immunology , Bone Marrow/pathology , Cathepsins , Flow Cytometry , Genotype , Immunophenotyping , Leukemia, Myeloid, Acute/genetics , Leukemia, Promyelocytic, Acute/genetics , Mice, Transgenic , Oncogene Proteins, Fusion/genetics , Serine Endopeptidases , Spleen/immunology , Spleen/pathology
SELECTION OF CITATIONS
SEARCH DETAIL